Sign in
Not yet recruitingNo phase

Following people in China with severe chronic rhinosinusitis with nasal polyps over time

Follows how people with nasal polyps are treated and how they do.

Key facts

Who runs it
Beijing Tongren Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
China CRSwNP Registry Study
Status
Not yet recruiting
People taking part
1,000 people, planned
Started
31 Oct 2026
Expected to end
31 Dec 2030
Type of study
Observational
Treatments tested
  • Routine Clinical Care for CRSwNP
Record updated
31 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people aged 12 or older in China with long-lasting sinus inflammation and nasal polyps on both sides. It only observes their usual care for 36 months.

Age
12 years or older
Sex
All sexes
Disease stage
Chronic rhinosinusitis with nasal polyps on both sides, confirmed by the Chinese 2024 guideline. Nasal Polyp Score of at least 4 out of 8, with at least 1 on each side. Nasal congestion score of at least 2 and/or loss of smell score of at least 2 (scale 0 to 3), over the previous 2 weeks.

Main reasons for not taking part

  • Pregnancy or breastfeeding
  • Another serious disease that is poorly controlled, or a recurring chronic or infectious disease
  • More than 14 units of alcohol per week, or past drug abuse
  • Other nose or sinus conditions, such as fungal sinusitis (except allergic fungal rhinosinusitis), sinusitis caused by teeth, cystic fibrosis, EGPA or ciliary syndromes
  • Conditions that may prevent completing follow-up, such as limited life expectancy or severe memory and thinking problems

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Aged 12 years or older at the time of signing the informed consent or assent form
  • Confirmed diagnosis of chronic rhinosinusitis with bilateral nasal polyps (CRSwNP) according to the Chinese Guideline for Diagnosis and Treatment of Chronic Rhinosinusitis (2024)
  • Baseline Nasal Polyp Score (NPS) of at least 4 on a scale of 0 to 8, with a score of at least 1 in each nasal cavity
  • At baseline, a self-reported Nasal Congestion Score (NCS) of at least 2 and/or Loss of Smell Score (LoS) of at least 2, each assessed on a scale of 0 to 3 based on symptoms during the previous 2 weeks
  • Able and willing to comply with long-term clinical follow-up and study assessments
  • Voluntary written informed consent. For minors, written informed consent from a parent or legal guardian and participant assent will be obtained as required by applicable regulations and ethics committee requirements

Who cannot take part

  • Other concomitant conditions that may interfere with the study, including but not limited to fungal sinusitis except allergic fungal rhinosinusitis, odontogenic sinusitis, antrochoanal polyps, eosinophilic granulomatosis with polyangiitis (EGPA/Churg-Strauss syndrome), cystic fibrosis, granulomatosis with polyangiitis, Young syndrome, Kartagener syndrome, or other ciliary dyskinesia syndromes
  • Presence of another poorly controlled serious disease, recurrent chronic disease, or infectious disease
  • History of excessive alcohol consumption, defined as more than 14 units of alcohol per week (1 unit equals 360 mL of beer, 45 mL of spirits containing 40% alcohol, or 150 mL of wine), or a history of drug abuse
  • Any medical, social, psychological, or personal condition that, in the investigator's judgment, may interfere with participation or reasonably be expected to prevent completion of scheduled follow-up visits and assessments, such as limited life expectancy, substance abuse, or severe cognitive impairment
  • Pregnancy or breastfeeding

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a long-lasting inflammatory disease of the nose and sinuses that can cause nasal blockage, loss of smell, nasal discharge, facial discomfort, sleep problems, and reduced quality of life.

Read full original descriptionShow less

POLARIS is a prospective, multicenter, real-world, non-interventional registry study. It will enroll approximately 1,000 adolescents and adults aged 12 years or older with bilateral CRSwNP at about 33 centers in China and follow them for 36 months. All treatment decisions will be made by the treating physicians according to routine clinical practice. The study will not assign participants to any treatment.

The study aims to describe the disease burden, underlying inflammatory characteristics, real-world treatment patterns, effectiveness of current treatments, and long-term outcomes of Chinese patients with CRSwNP. Key assessments will include changes in nasal symptoms measured by the Total Nasal Symptom Score, changes in disease-related quality of life measured by the 22-item Sino-Nasal Outcome Test, and the proportions of patients classified as cured, controlled, or uncontrolled at months 12, 24, and 36. The study will also examine treatment escalation, surgery, systemic corticosteroid and biologic use, health care and economic burden, safety events, and clinical characteristics and biomarkers associated with persistent high disease burden or frequent treatment escalation.

The group in the trial

  • CRSwNP Registry Cohort

    Approximately 1,000 adolescents and adults aged 12 years or older with bilateral chronic rhinosinusitis with nasal polyps (CRSwNP) who meet the protocol-defined nasal polyp and symptom criteria will be enrolled at approximately 33 centers in China and followed prospectively for 36 months. Participants will receive treatment selected by their treating physicians according to routine clinical practice. No treatment is assigned by the study.

    Treatment: Routine Clinical Care for CRSwNP

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
POLARIS: A Prospective, Multicenter Real-World Study to Investigate the Treatment Pattern and Prognostic Outcome in Chinese Severe Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Patients
Plain-language title
Following people in China with severe chronic rhinosinusitis with nasal polyps over timeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
31 August 2026